iScience · 2024 · 12 citations · 32 references
MedicineHealth SciencesClinical EpidemiologyEpidemiologic MethodsEpidemiologyCardiovascular DiseaseCause-specific MortalityDiabetes ControlDiabetes MellitusGlycemic ControlGlycemic MonitoringCause-specific Mortality AnalysisCox RegressionDiabetes MortalityGlycemic BiomarkersGlycemic TargetsMetabolic Risk AssessmentMultivariable AdjustmentProspective Cohort Data
The role of fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), and triglyceride-glucose index (TyG index) in predicting all-cause and cause-specific mortalities remains elusive. This study included 384,420 adults from the Shanghai cohort and the UK Biobank (UKB) cohort. After multivariable adjustment in the Cox models, FPG ≥7.0 mmol/L or HbA1c ≥ 6.5% increased the risk of all-cause mortality, FPG ≥5.6 mmol/L or HbA1c ≥ 6.5% increased CVD-related mortality, and higher or lower TyG index increased all-cause and CVD-related mortalities in the Shanghai cohort; FPG ≥5.6 mmol/L, HbA1c ≥ 5.7%, TyG index <8.31 or ≥9.08 increased the risks of all-cause, CVD-related, and cancer-related mortalities in the UKB cohort. FPG or HbA1c increased the discrimination of the conventional risk model in predicting all-cause and CVD-related mortalities in both cohorts. Thus, increased levels of FPG and HbA1c and U-shaped TyG index increase the risks of all-cause especially CVD-related mortalities.
32
K. G. M. M. Alberti, Paul Zimmet · Diabetic Medicine · 1998 · 15.3K citations
Fernando Guerrero‐Romero, Luis E. Simental‐Mendía, Manuel González-Ortı́z et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 2.3K citations · Full text
Medicine, Endocrinology, Diabetology +15